MedTrace Logo

The Effects of Sleeve Gastrectomy on Fractalkine

NCT07655739 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2026-06-18

No results posted yet for this study

Summary

Fractalkine (CX3CL1) is a unique chemokine involved in leukocyte adhesion, migration, and obesity-associated adipose tissue inflammation. Although bariatric surgery results in substantial weight loss and metabolic improvement, the temporal pattern of circulating CX3CL1 levels following laparoscopic sleeve gastrectomy (LSG) remains poorly understood. This study aimed to evaluate longitudinal changes in serum CX3CL1 levels after LSG and to investigate their association with postoperative weight loss.

Conditions

  • Obesity & Overweight

Sponsors & Collaborators

  • Mehmet Buğra Bozan

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-04
Primary Completion
2026-01-04
Completion
2026-02-04

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07655739 on ClinicalTrials.gov